Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05770609 |
| Consolidated Lead Sponsor | Shanghai Pharmaceuticals Holding Co |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 53 participants (ACTUAL) |
| Registered Start Date | 2023-06-19 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital, Sun-Yat Sen University | Guangzhou, China | Open Hospital Dossier -> |
| Nanfang Hospital, Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| The first affiliated hospital of Zhengzhou University | Zhengzhou, China | Open Hospital Dossier -> |
| Affiliated Hospital of Hebei University | Baoding, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.